Federal · H.R. 1076 · 118th Congress
Preventing the Financing of Illegal Synthetic Drugs Act
This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
First two sentences of the Congressional Research Service's summary · Congress.gov ↗
This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
Passed the House on May 22, 2023. Waiting on the Senate.
Find your representatives to see how yours voted.
First two sentences of the Congressional Research Service's summary · Congress.gov ↗. A plain-words version comes later. Official page ↗
Your reps
Find your representatives to see how yours voted.
Latest final vote: Passed · U.S. House · May 22, 2023
Official record ↗Constitution
Not yet mapped. The parts of the Constitution this bill touches appear here once an analysis is written and checked.
Want an analysis of this bill? A full analysis maps every provision it touches.
All votes
U.S. House · May 22, 2023 · Final passage
On Motion to Suspend the Rules and Pass, as Amended · Passed
Official record ↗By party
| Party | Yes | No | Present | Not voting |
|---|---|---|---|---|
| Republican | 175 | 1 | 0 | 9 |
| Democratic | 161 | 0 | 0 | 16 |
| Democrat | 5 | 0 | 0 | 1 |
| Independent | 1 | 0 | 0 | 0 |
By state (48)
| State | Yes | No | Present | Not voting |
|---|---|---|---|---|
| AL | 5 | 0 | 0 | 1 |
| AR | 4 | 0 | 0 | 0 |
| AZ | 7 | 0 | 0 | 0 |
| CA | 45 | 0 | 0 | 6 |
| CO | 4 | 0 | 0 | 1 |
| CT | 4 | 0 | 0 | 1 |
| DE | 1 | 0 | 0 | 0 |
| FL | 23 | 0 | 0 | 1 |
| GA | 11 | 0 | 0 | 0 |
| HI | 2 | 0 | 0 | 0 |
| IA | 4 | 0 | 0 | 0 |
| ID | 1 | 0 | 0 | 1 |
| IL | 14 | 0 | 0 | 3 |
| IN | 7 | 0 | 0 | 0 |
| KS | 3 | 0 | 0 | 0 |
| KY | 5 | 1 | 0 | 0 |
| LA | 4 | 0 | 0 | 1 |
| MA | 6 | 0 | 0 | 3 |
| MD | 5 | 0 | 0 | 0 |
| ME | 2 | 0 | 0 | 0 |
| MI | 11 | 0 | 0 | 1 |
| MN | 7 | 0 | 0 | 0 |
| MO | 5 | 0 | 0 | 1 |
| MS | 3 | 0 | 0 | 1 |
| MT | 1 | 0 | 0 | 0 |
| NC | 9 | 0 | 0 | 0 |
| NE | 3 | 0 | 0 | 0 |
| NH | 1 | 0 | 0 | 0 |
| NJ | 9 | 0 | 0 | 0 |
| NM | 3 | 0 | 0 | 0 |
| NV | 4 | 0 | 0 | 0 |
| NY | 20 | 0 | 0 | 0 |
| OH | 12 | 0 | 0 | 1 |
| OK | 5 | 0 | 0 | 0 |
| OR | 4 | 0 | 0 | 0 |
| PA | 15 | 0 | 0 | 0 |
| RI | 1 | 0 | 0 | 0 |
| SC | 6 | 0 | 0 | 0 |
| SD | 1 | 0 | 0 | 0 |
| TN | 7 | 0 | 0 | 1 |
| TX | 32 | 0 | 0 | 1 |
| UT | 3 | 0 | 0 | 0 |
| VA | 6 | 0 | 0 | 1 |
| VT | 1 | 0 | 0 | 0 |
| WA | 8 | 0 | 0 | 0 |
| WI | 6 | 0 | 0 | 1 |
| WV | 1 | 0 | 0 | 0 |
| WY | 1 | 0 | 0 | 0 |
The breakdown counts the 369 members whose positions are loaded; the totals above are the official record's.
Party is as each member's record lists it. Counts are of recorded positions, nothing more.
Every member's vote
369 members, by last name.
From the official record of each vote. A member who left office keeps their recorded position; their page shows the years they served.
Money
Lobbying reports for this bill haven't been searched yet. They're searched for every bill with a final-passage vote.
History
- May 22, 2023U.S. House: On Motion to Suspend the Rules and Pass, as Amended · Passed ↗
Recorded votes on this bill and the final action, as their sources record them. Committee and other steps without a recorded vote aren't listed; the official page has every action.
Final action
Not checked yet. The President's action on a bill appears here after the data sync looks it up.
From Congress.gov's record of the bill's actions.
Full text
Official summary (Congressional Research Service)
Preventing the Financing of Illegal Synthetic Drugs Act This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.
Source ↗